Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease

NCT00584740 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
59
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated prematurely after futility criterion was met at planned interim analysis of 41 patients.

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals